M Saccani 1*, E Buzzi 2, F Paccione 2. Licensee OAPL (UK) Creative Commons Attribution License (CC-BY) Effective Clinical Care.
|
|
- Lisa West
- 5 years ago
- Views:
Transcription
1 Page 1 of 5 Effective Clinical Care The relationship between autism spectrum disorder and attentiondeficit hyperactivity disorder: A critical review of the effects of DSM 5 criteria and the implications for treatment M Saccani 1*, E Buzzi 2, F Paccione 2 Abstract Introduction Autism Spectrum Disorder (ASD) and Attention Deficit/Hyperactivity Disorder (ADHD) are both severely impairing neurodevelopmental disorders. Interest in the co-occurance of Attention deficit/hyperactivity disorder(adhd)-like symptoms and Autism spectrum disorder (ASD) has grown in the last decade. Children with autism spectrum disorder (ASD) are frequently found to manifest symptoms of hyperactivity, inattention and impulsiveness, which are the cardinal symptoms of attention deficit/hyperactivity disorder (ADHD). The purpose of the present work is to review and critically discuss the studies reporting the co-occurrence of ADHD-like symptoms in individuals with formal diagnosis of ASD and the effectiveness of medications for ADHD symptoms in the ASD. Materials and methods We carried out a literature research and study selection by searching for published biomedical literature in PubMed. Results From a pool of 321 potentially relevant references we selected only reviews published during the past five years, focusing on co-occurrence of ASD and ADHD and their treatment. Our search yielded a total of 64 reviews that matched our search criteria. Conclusion DSM 5 currently permits co-diagnosis of ASD and ADHD. This option will *Corresponding author monica.saccani@ao-sanpaolo.it 1 San Paolo Hospital, Department of Childhood and Adolescence Neuropsichiatry, Milan, Italy 2 University of Milan, Milan, Italy facilitate new research approaches and will also have therapeutic implications. As shown in our review further research is needed to understand about developmental trajectories of the co-occurring disorders and to understand how severity of symptoms in one disorder may influence the emergence of symptoms in the other disorder. Individuals with ASD plus ADHD are more impaired than individuals with only ASD. This finding suggests that individuals with co-occurrence of the two disorders may need different treatment methods or intensities than those with only ASD. There is no consensus on the use drugs for individuals with ASD plus ADHD. The limited number of studies and the heterogeneity of results require further and larger RCTs for the assessment of the efficacy and tolerability of psychostimulants. Introduction Autism Spectrum Disorder (ASD) and Attention Deficit/Hyperactivity Disorder (ADHD) are both severely impairing neurodevelopmental disorders. Mental Disorders, fourth edition, textrevision (DSM-IV-TR) outlines Pervasive Developmental Disorders (PDDs) as a triad of qualitative impairments in social interaction, communication and restricted, repetitive and stereotyped behaviours. Delays or abnormal functioning must be evident in at least one area associated with autism before the age of three. PDDs include the categorical diagnoses of Autistic Disorder (AD), Asperger s Syndrome (AS), Childhood Disintegrative Disorder and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) 1. The worldwide prevalence of all ASDs has been estimated at approximately out of every 10,000 individuals 2. The CDC estimated the prevalence of Autism Spectrum Disorders (ASD) at approximately 0.9% of the population in the USA 3. The term autism spectrum disorders (ASDs) is a proposed revi sion of the current pervasive developmental disorders (PDDs) defined by the DSM- IV-TR criteria. Distinctions among ASD subtypes have been found to be inconsistent over time, variable across sites, and often associated with severity of language deficits and intellectual impairment rather than a different manifestation of inherent ASD features, such as social communication deficits and fixated interests and repetitive behaviours symptoms 4. Thus DSM 5 proposed a significant shift in the diagnostic conceptualization of ASD introducing the construct of a spectrum of autistic disorders 5. This construct aims to produce a clear diagnostic system that identifies the common characteristics of ASDs across all ages and ability levels. To describe this single category, the triad of impairments has been merged into a dyad: social/communication and restrictive and repetitive interests. The dyad has been proposed to embrace AD, AS and PDD-NOS in a dimensional approach 4,6,7. Attention Deficit/ Hyperactivity Disorder (ADHD) is a highly prevalent childhood-onset neuropsychiatric condition, with an estimated worldwide pooled prevalence of approximately 5% in school-age children 8. The major
2 Page 2 of 5 changes in DSM 5 classification of the disorder include increases in the amount of descriptive information for each symptom, changes in the way that information is gathered, changes in the way that the criteria are used for different age groups, clarification of the impact of current activity on symptoms, the nature of the disorder (neurodevelopmental) and the relationship between both autism and mood lability and ADHD 5. In the last decade, studies have reported increased prevalence of both attention deficit/ hyperactivity disorder and autism spectrum disorder, as well as more cases of co-occurring ADHD and ASD symptoms 9. The preclusion of a comorbid diagnosis of ADHD when the symptoms occur during the course of a PDD in DSM IV- TR fails to account for the many individuals with ASD who also meet full criteria for ADHD. Furthermore, many individuals with milder forms of ASD, such as Asperger s syndrome, may present clinically with initial concerns of ADHD symptoms 9. Since the clinician faces the challenges of managing ADHD symptoms (impairing inattention and/or hyperactivity impulsivity) in day-today clinical practice with individuals with ASDs, the aim of the present work is to review and critically discuss the studies reporting the cooccurrence of ADHD-like symptoms in individuals with formal diagnosis of ASD and the effectiveness of medications for ADHD symptoms in the ASD. Materials and methods We included studies assessing cooccurrence of ADHD-like symptoms (i. e., inattention and/or hyperactivity and/or impul sivity) and we made a literature research regarding the effectiveness of medications for ADHD symptoms in the ASD population. The study selections were made by searching for published biomedical literature in PubMed. The search criteria used were as follows: article types: review publication dates: 5 years species: humans languages: English key words: autism OR Asperger OR autism spectrum OR ASD AND Attention deficit hyperactivity disorder OR adhd AND drug therapy. The references of included studies were also screened to find additional pertinent studies not retrieved using the database search. Results Through a first research on PubMed, we have found 321 results that included some articles focusing on the characteristics of single disorders that have autistic traits in their clinical presentation or associated symptoms of inattention, some others on pharmacological treatments of single disorder (ADHD or ASD), their effectiveness and safety as well as several reviews that dealt with type of treatments other than drug therapy. On the basis of search criteria developed for this review, we selected only those reviews published during the past five years, excluding all articles focusing on a single disorder. Finally, we selected a total of 64 reviews that focused on the cooccurrence of ASD and ADHD and their treatment. During the analysis, we picked 30 reviews that we found more suitable for our study. The remaining 34 reviews were excluded, since some of them regard neurodevelopmental disorders and their conceptual issues, some others described genetic aetiology or genetic environmental interactions in aetiopathogenesis of neurodevelopmental disorders and still others discussed new therapeutic targets undergoing clinical trials. Discussion Co-occurrence of ASD and ADHD DSM-IV-TR stated that to meet criteria for ADHD, symptoms could not occur exclusively during the course of a PDD. However, a substantial literature has emerged refuting that idea. As summarized by Grzadzinski et al. the prevalence of ADHD symptoms in individuals with a primary clinical diagnosis of ASD has been reported to be between 13 and 50% in the general population and community-based studies, and between 20 and 85% in clinical samples 10. Conversely, autistic symptoms are often found in children with ADHD 10,11,12. Santosh et al. described two types of social impairment in ADHD: relationship difficulty related to environmental stressors and social communication deficits which related to symptoms of PDD 11. It has been shown that children with ADHD have similar difficulties in communication and restrictive repetitive behaviour as children with PDD 12. Symptoms of autism in children with ADHD appear to exceed those of the general population and significant correlations between symptoms of ADHD and symptoms of autism spectrum disorder have been shown in the general population 12,13. Recently St. Pourcain et al. explored the interrelationship between trajectories of co-occurring symptoms of ASD and ADHD examining the longitudinal pattern of association between socialcommunication deficits and hyperactive-inattentive symptoms in the general population, from childhood through adolescence. The study revealed various patterns of association between ASD and ADHD, with children with persistent hyperactive-inattentive symptoms also showing persistent social-communication deficits 14. The co-occurrence of ASD and ADHD has significant implications for level of functioning and treatment planning. Accumulating research comparing individuals with both ADHD and ASD to individuals with a single diagnosis (i.e., ADHD or ASD) suggests that cooccurring symptoms are associated with more impairment than single diagnoses 15, and children with ADHD and ASD experience more difficulty in daily situations, as compared to those with only one disorder 16, and have
3 Page 3 of 5 higher levels of additional psychopathology 17. Furthermore, recent work by Frazier et al. examined the prevalence of psychotropic medication use compared across individuals with ASD-only, ADHD-only, and an ASD with co-morbid ADHD. Youth characterized as having both ADHD and ASD are more likely to be taking psychiatric medication (58.2 %) than youth with ADHD (49 %) or ASD (34.3 %) alone 18. In other studies co-occurring ADHD and ASD seem to be less responsive to standard treatments for either disorder than individuals with pure forms of the disorders 19. While it seems clear that children suffering from both disorders are faced with a more severe condition and a higher degree of psychosocial problems, it remains unclear whether ADHD symptoms influence autistic psychopathology in particular. Recently Sprenger et al. conducted a large sample study 15 aiming to investigate the potential influence of ADHD symptoms on ASD psychopathology. The study included 126 patients with the diagnoses highfunctioning autism (HFA), atypical autism (AA) or Asperger s syndrome (AS), 70 ASD plus ADHD symptoms (ASD+) and 56 ASD without ADHD Symptoms (ASD-). Findings are in line with a study hypothesis that ASD+ participants would exhibit more autistic symptoms than ASDparticipants. The mechanisms underlying this phenotypic overlap between ADHD and ASD are poorly understood. A number of studies have been published noting that ADHD and ASD are distinct conditions that have several common cognitive and behavioural symptoms. Recent findings may indicate commonly shared genetic and neurobiological correlates 20,21,22. Pharmacological Treatment for cooccurring ASD and ADHD The new criteria in DSM 5 state that a diagnosis of ADHD should be allowed in the presence of ASD. This proposal, if implemented, would have an impact on a large number of individuals with ASD who would be more able to receive treatment for their ADHD symptoms. Pharmacological treatments constitute an important part of the comprehensive multimodal therapeutic strategy for ADHD. Drugs used to treat ADHD include stimulants (methylphenidate [MPH], dexmethylphenidate, dextroamphetamine, mixed amphetamine salts, dextromethamphetamine and lysdexamfetamine), as well as nonstimulant medications such as atomoxetine and a-2a adrenergic receptor agonists (clonidine and guanfacine). Psychostimulants are considered the first pharmacological choice in the management of ADHD 23. For ASD, current pharmacological treatments primarily target comorbid symptoms (e.g. irritability, aggression, hyperactivity) rather than core social and communication impairments. Atypical antipsychotics are currently first-line pharmacological agents used in treating irritability and associated behaviours in children with ASD. However, there is no consensus on the use of psychopharmacological treatments for autism. Cortese et al. conducted a comprehensive review of studies assessing the efficacy and tolerability of psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorder. Despite the limited amount of available research, the review highlights that empirical evidence from the controlled studies suggests that methylphenidate may be effec tive for ADHD-like symptoms in individuals with PDD/ASD 23. However the heterogeneity of the design and measures used in the reviewed studies cannot determine both the extent to which psychostimulants are effective and the proportion of ASD plus ADHD individuals who may benefit from this class of drugs. The largest controlled study of the efficacy and tolerability of MPH immediate release in children with ADHD is the RUPP Autism Network one. This study conducted a randomized, placebo controlled, crossover trial of methylphenidate with 72 children (ages, 5 14 years) who were diagnosed with autism who were also characterized with moderate-to-severe hyperactivity. Results indicated that stimulant medication was effective at reducing hyperactivity and impulsivity in approximately half of the participants, a response rate that is considerably lower than the rates of 70 to 80 % found in studies of methylphenidate for children with ADHD only 24. More adverse effects were reported in the children with ASD, and the highest tolerated dose was lower than that tolerated in children without ASD 24. Only one study to date has directly compared methylphenidate treatment response between children with ADHD and children characterized by ASD plus ADHD. This study reported overall improvement in ADHD symptoms, with few differences in treatment response between the groups 25. Some studies have assessed the moderator effect of clinically relevant variables and some of them have pointed to possible differential effects based on level of functioning (e.g., cognitive level, ASD severity). However there are contrast findings and recent works report that IQ may not affect the response to psychostimulants. This issue needs further standardized systematic research 23. Although these findings support the use of methylphenidate in children with both ADHD and ASD, the results were also consistent with prior studies that have suggested a greater need for side effect monitoring and lower dosing in the context of ASD. Other nonstimulant medications have been investigated for co-occurring
4 Page 4 of 5 ADHD and ASD symptoms. Atomoxetine, has demonstrated better tolerability than stimulant medications in individuals with cooccurring ADHD and ASD 17. A small placebo-controlled efficacy trial indicated positive effects in terms of the reduction of hyperactivity and impulsivity, but not inattention in youth with ASD, with fewer adverse events as compared to stimulant trials 26. Additional research using parents and teachers as informants showed significant reductions in ADHD symptoms among children with ADHD and ASD and side effects were rated as minimally present 19. Despite these promising findings, atomoxetine effectiveness may vary as a function of level of impairment: positive results for atomexetine are more evident among children with ASD who are cognitively higher functioning (defined as IQ >70) 19,23. In a separate investigation, atomoxetine treatment yielded no observed symptom reduction in a sample of children with high ASD symptom severity. Guanfacine is an alpha-2 adrenergic agonist recently approved for use with ADHD in an extended release formulation. Positive effects have been found in several studies using guanfacine for treatment of children with co-occurring ADHD and ASD symptoms. A retrospective analysis of 80 patients in the clinic indicated reduction in hyperactivity and inattention among children with ASD who were higher cognitively functioning (i.e., not in the cognitively impaired range) 19,23. Similarly, positive effects on parentand teacher-rated hyperactivity were also observed in an open trial examining children who had previously demonstrated lack of success with methylphenidate 27. Psycho-educational approach Limited work has examined psychosocial interventions for cooccurring ADHD and ASD. Multiple studies have demonstrated that combination pharmacological and psychosocial treatments are particularly effective for ADHD symptom management 28. This approach may also be indicated for children with co-occurring ADHD and ASD symptoms. Conclusion DSM 5 currently permits co-diagnosis of ASD and ADHD. Given that clinicians are routinely observing and treating individuals with co-occurring symptoms, DSM-5 changes will provide diagnostic clarification and will facilitate treatment studies to guide care. However, research specifically focusing on co-occurring ADHD and ASD has only emerged recently, and many studies have focused primarily on questions of aetiology and phenomenology. As shown in our review little is known about developmental trajectories of the cooccurring disorders. Unlike the longitudinal research by St. Pourcain et al., most current understanding of co-occurring ADHD and ASD stems from cross-sectional studies. Further research is needed to understand how severity of symptoms in one disorder may influence the emergence of symptoms in the other disorder. In addition to this and perhaps more important, we know that red flags associated with ASD can be observed prior to two years of age, whereas identifying atypical behaviours in the context of ADHD may be more difficult at very young ages. Multiple studies have found that early intensive ASD interventions can have a substantial impact on ASD symptoms therefore it will be important to determine whether these early interventions can also mitigate the later development of impairing ADHD symptoms. Prospective longitudinal studies of attention, social, communication and cognitive functioning are needed from the time that red flags of ASD are identified, so that the earlier this subset of children can be identified the earlier tailored intervention can be designed. In the matter of pharmacological treatment there is no consensus on the use of these psychostimulants for individuals with ASD plus ADHD. The limited number of studies and the heterogeneity of results require further and larger RCTs for the assessment of the efficacy and tolerability of these drugs, both immediate and extended release formulas. In summary research suggests that there is a psychopathological difference between ASD patients with and without additional ADHD symptoms, which may be rooted in neurobiological underpinnings. Our understanding of this topic and how etiological commonalities affect those with either diagnosis will surely improve with continued research. The option to diagnose comorbid ADHD and ASD in the DSM 5 will facilitate new research approaches and new therapeutic strategies. References 1. American Psychiatric Association. Mental Disorders. Fourth Edition, Text Revision: DSM-IV-TR. American Psychiatric Association; Washington, DC Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009; 65: ADDM. Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, Atlanta: CDC Lord C, Petkova E, Hus V, Gan W, Lu F, Martin D, et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry. 2012, Mar; 69(3): American Psychiatric Association. Mental Disorders. Fifth Edition: DSM-V. American Psychiatric Association; Washington, DC
5 Page 5 of 5 6. Majoury S, Lord C. What the DSM 5 portends for research, diagnosis and treatment of autism spectrum disorders. Curr Psychiatry Rep. 2012;14: Grzadzinski R, Huerta M, Lord C. DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes. Molecular autism. 2013;4(12): Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007; 164 (6): Reiersen AM, Todd RD. Cooccurrence of ADHD and autism spectrum disorders: phenomenology and treatment. Expert Rev Neurother. 2008;8: Grzadzinski R, Di MA, Brady E et al. Examining autistic traits in children with ADHD: does the autism spectrum extend to ADHD? J Autism Dev Disord. 2011;41(9): Santosh P, Mijovic A. Social impairment in hyperkinetic disorder. Eur Child Adolesc Psychiatry. 2004;13: Hattori J, Ogino T, Abiru K, Nakano K, Oka M, Ohtsuka Y. Are pervasive developmental disorders and attention-deficit/hyperactivity disorder distinct disorders? Brain Dev. 2006;28: Reiersen AM, Constantino JN, Volk HE, Todd RD. Autistic traits in a population-based ADHD twin sample. J Child Psychol Psychiatry. 2007;48: St Pourcain B, Mandy WP, Heron J, Golding J, Davey Smith G, Skuse DH. Links between-occurring socialcommunication and hyperactiveinattentive trait trajectories. J Am Acad Child Adolesc Psychiatry. 2011;50: Sprenger L,, Buhler E, Poustka L, Bach C, Heinzel-Gutenbrunner M, Kamp-Becker I, Bachmann C. Impact of ADHD symptoms on autism spectrum disorder symptom severity. Research Developmental Disabilities. 2013;34: Goldstein S, Schwebach AJ. The comorbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: results of a retrospective chart review. J Autism Dev Disord. 2004;34: Murray MJ. Attentiondeficit/hyperactivity disorder in the context of autism spectrum disorders. Curr Psychiatry Rep. 2010;12(5): Frazier TW, Shattuck PT, Narendorf SC, Cooper BP, Wagner M, Spitznagel EL. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attentiondeficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011;21: Ornstein Davis N & Kollins SH. Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. Neurotherapeutics. 2012; 9: Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping genetic influences on autistic and AD/HD behaviours in a community twin sample. Journal of Child Psychology and Psychiatry. 2008;49: van der Meer JMJ, Oerlemans AM, van Steijn DJ, Lappenschaar MGA, de Sonneville LMJ, Jan K Buitelaar JK, Rommelse NNJ. Are Autism Spectrum Disorder and Attention- Deficit/Hyperactivity Disorder Different Manifestations of One Overarching Disorder? Cognitive and Symptom Evidence From a Clinical and Population-Based Sample. J Am Acad Child Adolesc Psychiatry. 2012;51(11), Di Martino A, Zuo X, Kelly C, Grzadzinski R, Mennes M, Schvarcz A, Rodman J, Lord C, Castellanos FX, Milham MP. Shared and Distinct Intrinsic Functional Network Centrality in Autism and Attention- Deficit/Hyperactivity Disorder. Biol Psychiatry. 2013;74: Cortese S, Castelnau P, Morcillo C, Roux S, Bonnet-Brilhault F. Psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorders. Expert Rev Neurother. 2012,12(4): Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62: Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Child Care Health Dev. 2006;32: Arnold LE, Aman MG, Cook AM, et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry. 2006;45(10): Scahill L, Aman MG, McDougle CJ, et al. A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006;16: Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with attentiondeficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:
Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder
Neurotherapeutics DOI 10.1007/s13311-012-0126-9 REVIEW Treatment for Co-Occurring Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Naomi Ornstein Davis Scott H. Kollins # The American
More informationRole of ADHD medication in children with autism spectrum disorder. Pieter Hoekstra University of Groningen, Netherlands
Role of ADHD medication in children with autism spectrum disorder Pieter Hoekstra University of Groningen, Netherlands Symptoms of ADHD are highly prevalent in children with ASD Two independent chart reviews
More informationAutism/Pervasive Developmental Disorders Update. Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011
Autism/Pervasive Developmental Disorders Update Kimberly Macferran, MD Pediatric Subspecialty for the Primary Care Provider December 2, 2011 Overview Diagnostic criteria for autism spectrum disorders Screening/referral
More informationPHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE
ANTON et al. ORIGINAL PAPERS PHARMACOLOGICAL THERAPY OF AUTISM SPECTRUM DISORDERS IN THE CLINICAL PRACTICE Andra ISAC 2, Magdalena KWASIUK 1, Roxana ȘIPOȘ 1, Ioana MICLUȚIA 1, Viorel LUPU 1, Elena PREDESCU
More informationAUTISM SPECTRUM DISORDER: DSM-5 DIAGNOSTIC CRITERIA. Lisa Joseph, Ph.D.
AUTISM SPECTRUM DISORDER: DSM-5 DIAGNOSTIC CRITERIA Lisa Joseph, Ph.D. Autism Spectrum Disorder Neurodevelopmental disorder Reflects understanding of the etiology of disorder as related to alterations
More informationAutism Diagnosis and Management Update. Outline. History 11/1/2013. Autism Diagnosis. Management
Autism Diagnosis and Management Update Cathleen Small, PhD, BCBA-D Developmental Behavioral Pediatrics Maine Medical Partners Outline Autism Diagnosis Brief history New, DSM-5 diagnostic criteria Expressed
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationADHD, ASC & Asperger s
ADHD, ASC & Asperger s Dr Simon Bignell Senior Lecturer in Psychology University of Derby s.bignell@derby.ac.uk, 01332 593043 Twitter @MiltonBroome Keynote Lecture at The ADHD Foundation 6 th Annual Conference
More informationPsychopharmacology of Autism Spectrum Disorder
Psychopharmacology of Autism Spectrum Disorder Christopher J. McDougle, MD Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral Hospital
More informationFact Sheet 8. DSM-5 and Autism Spectrum Disorder
Fact Sheet 8 DSM-5 and Autism Spectrum Disorder A diagnosis of autism is made on the basis of observed behaviour. There are no blood tests, no single defining symptom and no physical characteristics that
More informationINFORMATION PAPER: INTRODUCING THE NEW DSM-5 DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDER
INFORMATION PAPER: INTRODUCING THE NEW DSM-5 DIAGNOSTIC CRITERIA FOR AUTISM SPECTRUM DISORDER What is the DSM-5? The Diagnostic and Statistical Manual of Mental Disorders (the DSM) is developed by the
More informationTable 1: Comparison of DSM-5 and DSM-IV-TR Diagnostic Criteria. Autism Spectrum Disorder (ASD) Pervasive Developmental Disorders Key Differences
Comparison of the Diagnostic Criteria for Autism Spectrum Disorder Across DSM-5, 1 DSM-IV-TR, 2 and the Individuals with Disabilities Act (IDEA) 3 Definition of Autism Colleen M. Harker, M.S. & Wendy L.
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder
Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More information3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM
Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive
More informationWhat happens to children who move off the autism spectrum? Clinical follow-up study
Pediatrics International (2017) 59, 416 421 doi: 10.1111/ped.13202 Original Article What happens to children who move off the autism spectrum? Clinical follow-up study Nahit Motavalli Mukaddes, 1 Tuba
More informationUnderstanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct Disorders. Prof.
Understanding the Use of Psychotherapy and Psychotropic Medications for Oppositional Defiance and Conduct s Prof. Daniel Kaplin College of Staten Island One of the new chapters in the Diagnostic and Statistical
More informationResearchers probe genetic overlap between ADHD, autism
NEWS Researchers probe genetic overlap between ADHD, autism BY ANDREA ANDERSON 22 APRIL 2010 1 / 7 Puzzling link: More than half of children with attention deficit hyperactivity disorder meet the diagnostic
More informationDiagnosis Advancements. Licensee OAPL (UK) Creative Commons Attribution License (CC-BY) Research study
Page 1 of 6 Diagnosis Advancements Relationship between Stereotyped Behaviors and Restricted Interests (SBRIs) measured on the Autism Diagnostic Observation Schedule (ADOS) and diagnostic results. C Schutte
More informationOklahoma Psychological Association DSM-5 Panel November 8-9, 2013 Jennifer L. Morris, Ph.D.
Oklahoma Psychological Association DSM-5 Panel November 8-9, 2013 Jennifer L. Morris, Ph.D. DSM-5 continues developmental progression, starting with disorders that are observed in early life. Disorders
More informationPiecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder
Piecing the Puzzle Together: Pharmacologic Approaches to Behavioral Management in Autism Spectrum Disorder Hannah Sauer, PharmD PGY1 Pediatric Pharmacy Resident Mayo Clinic 2015 MFMER slide-1 Objectives
More informationAutism Spectrum Disorder and Mental Health Challenges in Youth
Autism Spectrum Disorder and Mental Health Challenges in Youth Management in the Primary Care Setting February 13, 2016 Rebecca Marshall, MD, MPH Outline DSM V Criteria Comorbidities Behavioral treatments
More informationThis is a pre-publication version of the article published in the Journal of Clinical Practice in Speech Language Pathology
CHANGING THE WAY WE DIAGNOSE AUTISM 1 This is a pre-publication version of the article published in the Journal of Clinical Practice in Speech Language Pathology Changing the way we diagnose autism: Implications
More informationResearch Article Received: ; Revised: ; Accepted: Background: Objectives: Patients and Methods: Results: Conclusions: 1.
J Compr Ped. 2014 August; 5(3): e21730. Published online 2014 August 25. DOI: 10.17795/compreped-21730 Research Article Early Detection of Autism Spectrum Disorders in Children With Attention Deficit Hyperactivity
More informationPractical Psychopharmacology for More Complex Mental Health Presentations
MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 1: Stimulants Dr. Ajit Ninan & Joel Lamoure 1 Practical Psychopharmacology for More
More informationCONTROVERSIES AND NEW DIRECTIONS
BIPOLAR Introduction DISORDER IN CHILDHOOD AND EARLY ADOLESCENCE Introduction MELISSA P. D ELBELLO, DAVID AXELSON, and BARBARA GELLER CONTROVERSIES AND NEW DIRECTIONS Although the existence and diagnostic
More informationSeventy years since Kanner s account, what do we think causes autism in 2013?
www.gel.bbk.ac.uk @gelironald Seventy years since Kanner s account, what do we think causes autism in 2013? 24 th September 2013 Karolinska Institutet Dr Angelica Ronald Genes Environment Lifespan laboratory,
More informationAttention-Deficit/Hyperactivity Disorder Nathan J. Blum, M.D.
ADHD in Preschool Children Preschool ADHD: When Should We Diagnose it & How Should We Treat it? Professor of Pediatrics Diagnosis of ADHD in Preschool Children: Impact of DSM-IV Is Preschool ADHD Associated
More informationFactors Influencing How Parents Report. Autism Symptoms on the ADI-R
Factors Influencing How Parents Report Autism Symptoms on the ADI-R Diana Wexler Briarcliff High School Diana Wexler Briarcliff High School 1 Abstract Background: The Autism Diagnostic Interview - Revised
More informationPreliminary Report on the Impact of Smartglasses-based Behavioral and Social Communication Aid on Hyperactivity in Children and Adults with Autism.
Preliminary Report on the Impact of Smartglasses-based Behavioral and Social Communication Aid on Hyperactivity in Children and Adults with Autism. Arshya Vahabzadeh 1,3, Neha U. Keshav 1, Joseph P. Salisbury
More informationINTRODUCTION AND OVERVIEW
Chapter 1 INTRODUCTION AND OVERVIEW More children and youth are being diagnosed with autism spectrum disorder (ASD) than ever before. Epidemiological research indicates a progressively rising prevalence
More informationEvidence for shared genetic influences on selfreported ADHD and autistic symptoms in young adult Australian twins
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2008 Evidence for shared genetic influences on selfreported ADHD and autistic symptoms in young adult Australian
More informationUpdate on DSM 5 and the Genomics of ASD
Update on DSM 5 and the Genomics of ASD Peter Szatmari MD Offord Centre for Child Studies, McMaster University and McMaster Children s Hospital Financial Disclosure The Canadian Institutes of Health Research
More informationAggression (Severe) in Children under Age 6
Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric
More informationtopic : Co-Morbid Conditions by Cindy Ring, MSW, LSW and Michele LaMarche, BCBA
ABA Literature Summary e-newsletter OCTOBER 2011 ISSUE 5 topic : Co-Morbid Conditions by Cindy Ring, MSW, LSW and Michele LaMarche, BCBA 1. Co-Morbidity Rates and Types in Individuals with Autism............
More informationThe Clinical Progress of Autism Spectrum Disorders in China. Xi an children s hospital Yanni Chen MD.PhD
The Clinical Progress of Autism Spectrum Disorders in China Xi an children s hospital Yanni Chen MD.PhD Conception The autism spectrum disorders (ASDs) are neurodevelopmental disability characterized by
More informationA Longitudinal Pilot Study of Behavioral Abnormalities in Children with Autism
Volume 1, Issue 4 Research Article A Longitudinal Pilot Study of Behavioral Abnormalities in Children with Autism Robin A. Libove 1, Thomas W. Frazier 2, Ruth O Hara 1, Jennifer M. Phillips 1, Booil Jo
More informationAutism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes? What is Autism? What are the Autism
More informationDevelopmental Disorders also known as Autism Spectrum Disorders. Dr. Deborah Marks
Pervasive Developmental Disorders also known as Autism Spectrum Disorders Dr. Deborah Marks Pervasive Developmental Disorders Autistic Disorder ( Autism) - Kanner Asperger Syndrome Pervasive Developmental
More informationAutism Spectrum Disorder What is it?
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes? What is Autism? What are the Autism
More informationMisunderstood Girls: A look at gender differences in Autism
Misunderstood Girls: A look at gender differences in Autism By Lauren Lowry Hanen Certified SLP and Clinical Staff Writer Several years ago I worked on a diagnostic assessment team. I remember the first
More informationDr Jane McCarthy MB ChB MD MRCGP FRCPsych
Dr Jane McCarthy MB ChB MD MRCGP FRCPsych Consultant Psychiatrist in Intellectual Disability, East London NHS Foundation Trust and Visiting Senior Lecturer, Institute of Psychiatry, Psychology & Neuroscience,
More informationAn Autism Primer for the PCP: What to Expect, When to Refer
An Autism Primer for the PCP: What to Expect, When to Refer Webinar November 9, 2016 John P. Pelegano MD Chief of Pediatrics Hospital for Special Care Disclosures None I will not be discussing any treatments,
More informationAttention Deficit Hyperactivity Disorder Overview and New Perspectives
1st Annual Regional Psychiatry Conference Psychiatry for the Non-Psychiatrist Attention Deficit Hyperactivity Disorder Overview and New Perspectives Thomas B. Henry, MD Board Certified Child & Adolescent
More information11/2/2016 INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM FACULTY DISCLOSURE
FACULTY DISCLOSURE INSIDE THE MIND OF A CHILD PSYCHIATRIST: PROBLEM BEHAVIORS IN CHILDREN WITH AUTISM KristinDawson, MD Assistant Professor University of Kentucky No commercial conflicts of Interest Salary
More informationAttention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6
in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,
More informationDeconstructing the DSM-5 By Jason H. King
Deconstructing the DSM-5 By Jason H. King Assessment and diagnosis of autism spectrum disorder For this month s topic, I am excited to share my recent experience using the fifth edition of the Diagnostic
More informationThe Nuts and Bolts of Diagnosing Autism Spectrum Disorders In Young Children. Overview
The Nuts and Bolts of Diagnosing Autism Spectrum Disorders In Young Children Jessica Greenson, Ph.D. Autism Center University of Washington Overview Diagnostic Criteria Current: Diagnostic & Statistical
More informationDr Jane McCarthy Consultant Psychiatrist, East London NHS Foundation Trust & Visiting Senior Lecturer, Department of Forensic & Neurodevelopmental
Dr Jane McCarthy Consultant Psychiatrist, East London NHS Foundation Trust & Visiting Senior Lecturer, Department of Forensic & Neurodevelopmental Sciences Department, King s College London Prevalence
More informationAutism Spectrum Disorders in DSM-5
Autism Spectrum Disorders in DSM-5 JILL FODSTAD, PH.D., HSPP, BCBA -D A S S I S TA N T P R O F E S S O R O F C L I N I C A L P SYC H O LO GY D E PA RT M E N T O F P SYC H I AT RY I U S C H O O L O F M
More informationPharmacotherapy of ADHD with Non- Stimulants
Pharmacotherapy of ADHD with Non- Stimulants Timothy E. Wilens, M.D. Chief, Division of Child and Adolescent Psychiatry, (Co)Director of Center for Addiction Medicine, Massachusetts General Hospital Massachusetts
More informationThe Use of ADHD Medication in the Pediatric Population
The Use of ADHD Medication in the Pediatric Population Shirin Madzhidova, PharmD Pediatric Pharmacotherapy Fellow Nova Southeastern University Objectives Discuss the importance of treatment with medications
More informationAttention-Deficit/Hyperactivity Disorder in Adults with High-Functioning Pervasive Developmental Disorders in Japan
Open Journal of Psychiatry, 2014, 4, 372-380 Published Online October 2014 in SciRes. http://www.scirp.org/journal/ojpsych http://dx.doi.org/10.4236/ojpsych.2014.44043 Attention-Deficit/Hyperactivity Disorder
More informationCorrespondence should be addressed to Vitharon Boon-yasidhi;
Psychiatry Journal, Article ID 136158, 4 pages http://dx.doi.org/10.1155/2014/136158 Research Article Adverse Effects of Risperidone in Children with Autism Spectrum Disorders in a Naturalistic Clinical
More informationADHD in the Preschool Aged Child
ADHD in the Preschool Aged Child (PATS) 11/2/2013 Stephen Meister MD, MHA, FAAP The Edmund N Ervin Pediatric Center (PATS) National Institute of Mental Health study First papers published in 2006 after
More informationMEDICAL POLICY SUBJECT: APPLIED BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS
MEDICAL POLICY PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationPediatrics Grand Rounds 9 April University of Texas Health Science Center at San Antonio. Overview. Prevalence of ASD (Cont.) Prevalence of ASD
9 April 200 Overview Diagnosis and Treatment of Autism Spectrum Disorders Steven R. Pliszka, M.D. Professor and Vice Chair Chief, Division of Child and Adolescent Psychiatry Department of Psychiatry The
More informationPRESCRIBING PHYSICIANS PLEASE READ
PRESCRIBING PHYSICIANS PLEASE READ USADA s mission is to protect the rights of clean athletes. Some athletes need to use stimulants to manage ADD/ADHD and the anti-doping community acknowledges and respects
More informationBipolar disorder in children and young people on the autism spectrum
Exclusively sponsored by: Bipolar disorder in children and young people on the autism spectrum We are members of a multidisciplinary tertiary second opinion referral service for youth (under age 18 years)
More informationClinical Practice Pathways for Evaluation and Medication Choice for Attention-Deficit/Hyperactivity Disorder Symptoms in Autism Spectrum Disorders
SUPPLEMENT ARTICLE Clinical Practice Pathways for Evaluation and Medication Choice for Attention-Deficit/Hyperactivity Disorder Symptoms in Autism Spectrum Disorders AUTHORS: Rajneesh Mahajan, MD, a Maria
More informationLiving with the Spectrum: Autism and Family Life
Living with the Spectrum: Autism and Family Life One Approach to Teaching Family Studies Students about Interdisciplinary Care Jennifer S. Reinke, PhD, LAMFT, CFLE University of Wisconsin Stout a cluster
More information6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.
Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice 1 Guideline title SCOPE Autism: the management and support of children and young people on the autism spectrum 1.1 Short
More informationTony Charman: Longitudinal studies for autism research
VIEWPOINT Tony Charman: Longitudinal studies for autism research BY TONY CHARMAN 24 JANUARY 2012 1 / 8 2 / 8 3 / 8 4 / 8 Facing forward: When Tony Charman first began studying autism in the 1980s, long-term
More informationDisclosures. Autism Society of Wisconsin. Case 2. Case 1. Case 3. Case 4 3/29/2018. Medication treatment for people with Autism Spectrum Disorder
Medication treatment for people with Autism Spectrum Disorder Autism Society of Wisconsin April 20, 2018 Richard P. Barthel, M.D. Disclosures In accordance with the ACCME policy on relevant financial disclosure,
More informationCOMORBIDITY PREVALENCE AND TREATMENT OUTCOME IN CHILDREN AND ADOLESCENTS WITH ADHD
COMORBIDITY PREVALENCE AND TREATMENT OUTCOME IN CHILDREN AND ADOLESCENTS WITH ADHD Tine Houmann Senior Consultant Child and Adolescent Mental Health Center, Mental Health Services Capital Region of Denmark
More informationAutism Spectrum Disorder What is it?
Autism Spectrum Disorder What is it? Robin K. Blitz, MD Director, Developmental Pediatrics Resident Autism Diagnostic Clinic Lecture Series #1 Learning Objectives What can we talk about in 20 minutes?
More informationWeek 2: Disorders of Childhood
Week 2: Disorders of Childhood What are neurodevelopmental disorders? A group of conditions with onset in the developmental period Disorders of the brain The disorders manifest early in development, often
More informationLow Functioning Autism Spectrum Disorder
Low Functioning Autism Spectrum Disorder Walter E. Kaufmann Center for Translational Research Greenwood Genetic Center Department of Neurology, Boston Children s Hospital MIT Simons Center for the Social
More informationWhat s in a name? Autism is a Syndrome. Autism Spectrum Disorders 6/30/2011. Autism Spectrum Disorder (ASD) vs Pervasive Developmental Disorder (PDD)
Autism is a Syndrome A group of symptoms that tend to cluster together Share a common natural history Not necessarily a single etiology What s in a name? Autism Spectrum Disorder (ASD) vs Pervasive Developmental
More informationImpact of Comorbidities on Self-Esteem of Children with Attention Deficit Hyperactivity Disorder
The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 3, Issue 3, No.1, DIP: 18.01.011/20160303 ISBN: 978-1-365-03416-9 http://www.ijip.in April - June, 2016 Impact
More informationTitle: ADHD: Symptom Reduction in Follow up Period CMS ID: PP3 NQF #: N/A
Source(s) Office of the National Coordinator for Health Information Technology/Centers for Medicare & Medicaid Services Measure Domain Effective Clinical Care: Outcome Brief Abstract Description Percentage
More informationBrief Report: Attention Effect on a Measure of Social Perception
J Autism Dev Disord (2008) 38:1797 1802 DOI 10.1007/s10803-008-0570-x BRIEF REPORT Brief Report: Attention Effect on a Measure of Social Perception Jodene Goldenring Fine Æ Margaret Semrud-Clikeman Æ Brianne
More informationPharmacological interventions for children with Disruptive Behaviour Disorders or Conduct Disorder or Oppositional Defiant Disorder
updated 2012 Pharmacological interventions for children with Disruptive Behaviour Disorders or Conduct Disorder or Oppositional Defiant Disorder Q8: What is the effectiveness, safety and role of pharmacological
More informationAttention Deficit Hyperactive Disorder (ADHD)
E-Resource September, 2015 Attention Deficit Hyperactive Disorder (ADHD) Attention Deficit Hyperactivity Disorder (ADHD) is the most common childhood behavioral health concern noticed in primary care.
More informationDSM-IV Criteria. (1) qualitative impairment in social interaction, as manifested by at least two of the following:
DSM-IV Criteria Autistic Disorder A. A total of six (or more) items from (1), (2), and (3), with at least two from (1), and one each from (2) and (3): (1) qualitative impairment in social interaction,
More informationAutistic traits in a population-based ADHD twin sample
Journal of Child Psychology and Psychiatry 48:5 (2007), pp 464 472 doi:10.1111/j.1469-7610.2006.01720.x Autistic traits in a population-based ADHD twin sample Angela M. Reiersen, 1 John N. Constantino,
More informationADHD and Comorbid Conditions A Conceptual Model
ADHD and Comorbid Conditions A Conceptual Model Thomas E. Brown PhD. Assistant Clinical Professor of Psychiatry, Yale University School of Medicine and Associate Director of the Yale Clinic for Attention
More informationBipolar Disorder in Youth
Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset
More informationPerspective Truth on ADHD & Medications. Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry
Perspective Truth on ADHD & Medications Thomas L. Matthews, M.D. Associate Dean of Student Affairs Professor of Psychiatry Disclosures National Institute of Health ADHD and Aggression Study Co- Investigator
More informationTo evaluate psychostimulants in the. ADHD treatment and academic performance: A case series. Brief Report. Practice recommendations
Brief Report ADHD treatment and academic performance: A case series Louis H. McCormick, MD Franklin Family Care Center, Franklin, Louisiana Practice recommendations Most new cases of attention deficit
More informationChallenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd,
Challenging ASD Cases November 11, 2017 Melanie Penner, MD, MSc, FRCPC @drmelpenner Mohammad Zubairi, MD, MEd, FRCPC @md_mszubairi Learning Objectives By the end of this workshop, participants will: 1)
More informationWHAT IS AUTISM? Chapter One
WHAT IS AUTISM? Chapter One Autism is a life-long developmental disability that prevents people from understanding what they see, hear, and otherwise sense. This results in severe problems with social
More informationA Validation Study of the Korean Child Behavior Checklist in the Diagnosis of Autism Spectrum Disorder and Non-Autism Spectrum Disorder
ORIGINAL ARTICLE J Korean Acad Child Adolesc Psychiatry 2019;30(1):9-16 https://doi.org/10.5765/jkacap.180018.1 pissn 1225-729X / eissn 2233-9183 A Validation Study of the Korean Child Behavior Checklist
More informationJ. Indian Assoc. Child Adolesc. Ment. Health 2014; 10(3): Editorial
145 J. Indian Assoc. Child Adolesc. Ment. Health 2014; 10(3):145-149 Editorial Is ADHD being over diagnosed? An Indian perspective Vivek Agarwal MD, Sujit Kar MD Address for correspondence: Dr. Vivek Agarwal,
More informationDevelopmental dissociation, deviance, and delay: occurrence of attentiondeficit hyperactivity
Developmental dissociation, deviance, and delay: occurrence of attentiondeficit hyperactivity disorder in individuals with and without borderline-to-mild intellectual disability Robert G Voigt* MD; William
More informationDifferentiating MDD vs. Bipolar Depression In Youth
Differentiating MDD vs. Bipolar Depression In Youth Mai Uchida, M.D. Staff Physician Clinical and Research Programs in Pediatric Psychopharmacology Massachusetts General Hospital Disclosures Neither I
More informationAdaptive Behavior Profiles in Autism Spectrum Disorders
Adaptive Behavior Profiles in Autism Spectrum Disorders Celine A. Saulnier, PhD Associate Professor Emory University School of Medicine Director of Research Operations Marcus Autism Center Vineland Adaptive
More informationCreation and Use of the Pervasive Developmental Disorder Behavior Inventory (PDDBI) Parent Form
Spanish Translation Creation and Use of the Pervasive Developmental Disorder Behavior Inventory (PDDBI) Parent Form Spanish Translation Amy Kovacs Giella, BA Executive Summary Approximately 13% of the
More informationDr Keith Ganasen Department of Psychiatry UCT
Dr Keith Ganasen Department of Psychiatry UCT A. Significantly subaverage intellectual functioning: an IQ of approximately 70 or below on an individually administered IQ test B. Concurrent deficits or
More informationBEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS
Page: 1 of 7 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title APPLIED BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM Policy Number 3.01.11 Category Behavioral Health/ Government Mandate
More informationDSM-IV: Diagnostic And Statistical Manual Of Mental Disorders By American Psychiatric Association READ ONLINE
DSM-IV: Diagnostic And Statistical Manual Of Mental Disorders By American Psychiatric Association READ ONLINE This second edition of the Diagnostic and Statistical Manual of Mental. Disorders.. With a
More informationForeword: Counting Sheep Harsh K. Trivedi. Preface Jess P. Shatkin and Anna Ivanenko
Pediatric Sleep Disorders Foreword: Counting Sheep Harsh K. Trivedi xiii Preface Jess P. Shatkin and Anna Ivanenko xv Normal Sleep in Children and Adolescents 799 Valerie McLaughlin Crabtree and Natalie
More information1/30/2018. Adaptive Behavior Profiles in Autism Spectrum Disorders. Disclosures. Learning Objectives
Adaptive Behavior Profiles in Autism Spectrum Disorders Celine A. Saulnier, PhD Associate Professor Emory University School of Medicine Vineland Adaptive Behavior Scales, Third Edition 1 Disclosures As
More informationCADDAC, a national not-for-profit organization that provides leadership in education, awareness and advocacy for Attention Deficit Hyperactivity Disor
CADDAC, a national not-for-profit organization that provides leadership in education, awareness and advocacy for Attention Deficit Hyperactivity Disorder (ADHD) organizations and individuals with ADHD
More informationASD (hyperactivity) 3 rd LINE TREATMENT Initial liquid dose mg 2. - ADHD symptoms without sleep
Generic Name Label Name Dosing by Disorder RITALIN, RITALIN LA, CONCERTA, METADATE ER, 2 ND LINE TREATMENT 2 ND LINE TREATMENT METADATE CD, MPH ER, Initial liquid dose 1-5 mg 1,2 Initial liquid dose 1-5mg
More informationWhat About Health 3: Challenging Behaviors
The title of this presentation is What About Health. I m. In this presentation I will discuss a number of health and mental health issues related to children with ASD. 1 Now I am going to switch to discussing
More informationLessons from Population-Based Surveillance for ASD
Lessons from Population-Based Surveillance for ASD Marshalyn Yeargin-Allsopp, MD Medical Epidemiologist Developmental Disabilities Branch National Center on Birth Defects and Developmental Disabilities
More informationAlpha-2 Agonists. Antipsychotics
Table 5: Randomized Controlled Trials of Psychotropic Medications in Children and Adolescents with ASD Agent Study Target Symptoms Dose Demographics Significant Side Clonidine Guanfacine Jaselskis et al.,
More informationAnalysis of new diagnostic criteria for autism sparks debate
NEWS Analysis of new diagnostic criteria for autism sparks debate BY EMILY SINGER 2 APRIL 2012 1 / 6 Draft definition: A new study questions the sensitivity of the new DSM-5's diagnostic criteria. A new
More information